Details for Patent: 5,256,664
✉ Email this page to a colleague
Summary for Patent: 5,256,664
Title: | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
Abstract: | 2-(3-[4-(3-Halophenyl)-1-piperazinyl]propyl derivatives of certain 4-alkyl- or 4-phenoxyalkyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and triazol-3,5-diones are psychotropic agents having promise as antidepressants by virtue of their receptor site binding affinity profiles and animal pharmacology. |
Inventor(s): | Mayol; Robert F. (Durham, CT), Luke; George M. (LaFayette, NY) |
Assignee: | Bristol-Myers Squibb Company (New York, NY) |
Application Number: | 07/875,044 |
Patent Claim Types: see list of patent claims | Compound; Composition; Dosage form; | More… ↓ |
Drugs Protected by US Patent 5,256,664
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,256,664
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 199253 | ⤷ Subscribe | |||
Canada | 2094890 | ⤷ Subscribe | |||
Germany | 69329942 | ⤷ Subscribe | |||
Denmark | 0568437 | ⤷ Subscribe | |||
European Patent Office | 0568437 | ⤷ Subscribe | |||
Spain | 2154644 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |